Association of HER2/neu with complete response in breast carcinoma with neoadjuvant chemotherapy

被引：0
|
作者：
Peiró, G [1 ]
Adrover, E [1 ]
Aranda, FI [1 ]
Alenda, C [1 ]
Payá, A [1 ]
Seguí, J [1 ]
机构：
[1] Hosp Gen Univ, Alacant, Spain
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
164
引用
收藏
页码：38A / 38A
页数：1
相关论文
共 50 条
  • [31] β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis
    Drebber, Uta
    Madeja, Martin
    Odenthal, Margarete
    Wedemeyer, Inga
    Moenig, Stefan P.
    Brabender, Jan
    Bollschweiler, Elfriede
    Hoelscher, Arnulf H.
    Schneider, Paul M.
    Dienes, Hans P.
    Vallboehmer, Daniel
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (09) : 1127 - 1134
  • [32] HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Hou, Yanjun
    Nitta, Hiroaki
    Wei, Lai
    Banks, Peter M.
    Portier, Bryce
    Parwani, Anil V.
    Li, Zaibo
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (02) : 447 - 457
  • [33] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [34] Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer
    Ustaalioglu, Bala Basak Oven
    Vardar, Fugen Aker
    Bilici, Ahmet
    Gurleyik, Gunay
    Erkol, Burcak
    Kefeli, Umut
    Aliustaoglu, Mehmet
    JOURNAL OF BUON, 2014, 19 (04): : 879 - 886
  • [35] HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Yanjun Hou
    Hiroaki Nitta
    Lai Wei
    Peter M. Banks
    Bryce Portier
    Anil V. Parwani
    Zaibo Li
    Breast Cancer Research and Treatment, 2017, 166 : 447 - 457
  • [36] β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis
    Uta Drebber
    Martin Madeja
    Margarete Odenthal
    Inga Wedemeyer
    Stefan P. Mönig
    Jan Brabender
    Elfriede Bollschweiler
    Arnulf H. Hölscher
    Paul M. Schneider
    Hans P. Dienes
    Daniel Vallböhmer
    International Journal of Colorectal Disease, 2011, 26
  • [37] HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer
    Zhao, Jing
    Krishnamurti, Uma
    Zhang, Chao
    Meisel, Jane
    Wei, Zhimin
    Suo, Aili
    Aneja, Ritu
    Li, Zaibo
    Li, Xiaoxian
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [38] Noninvasive imaging signatures of HER2 and HR using ADC in invasive breast cancer: repeatability, reproducibility, and association with pathological complete response to neoadjuvant chemotherapy
    Teng, Xinzhi
    Zhang, Jiang
    Zhang, Xinyu
    Fan, Xinyu
    Zhou, Ta
    Huang, Yu-hua
    Wang, Lu
    Lee, Elaine Yuen Phin
    Yang, Ruijie
    Cai, Jing
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [39] Noninvasive imaging signatures of HER2 and HR using ADC in invasive breast cancer: repeatability, reproducibility, and association with pathological complete response to neoadjuvant chemotherapy
    Xinzhi Teng
    Jiang Zhang
    Xinyu Zhang
    Xinyu Fan
    Ta Zhou
    Yu-hua Huang
    Lu Wang
    Elaine Yuen Phin Lee
    Ruijie Yang
    Jing Cai
    Breast Cancer Research, 25
  • [40] 2 CASES WITH OBJECTIVE COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY OF BREAST-CARCINOMA
    LINSK, JA
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1986, 3 (02): : 119 - 121
12345